Bank of New York Mellon Corp Acquires 36,642 Shares of Waldencast plc (NASDAQ:WALD)

Bank of New York Mellon Corp grew its holdings in Waldencast plc (NASDAQ:WALDFree Report) by 73.6% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 86,409 shares of the company’s stock after acquiring an additional 36,642 shares during the period. Bank of New York Mellon Corp’s holdings in Waldencast were worth $814,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Strs Ohio acquired a new stake in shares of Waldencast in the second quarter valued at approximately $32,000. American International Group Inc. acquired a new stake in shares of Waldencast in the second quarter valued at approximately $75,000. SG Americas Securities LLC acquired a new stake in shares of Waldencast in the third quarter valued at approximately $151,000. Barclays PLC lifted its position in shares of Waldencast by 440.0% in the second quarter. Barclays PLC now owns 4,093 shares of the company’s stock valued at $31,000 after buying an additional 3,335 shares during the last quarter. Finally, Geode Capital Management LLC acquired a new stake in shares of Waldencast in the fourth quarter valued at approximately $111,000. 19.93% of the stock is owned by institutional investors and hedge funds.

Waldencast Stock Performance

Waldencast stock opened at $6.91 on Friday. The stock’s fifty day moving average price is $9.55 and its two-hundred day moving average price is $8.58. Waldencast plc has a one year low of $5.00 and a one year high of $12.00.

Analyst Upgrades and Downgrades

Separately, Telsey Advisory Group reiterated an “outperform” rating and set a $12.00 target price on shares of Waldencast in a research note on Thursday, February 1st.

Check Out Our Latest Stock Analysis on Waldencast

Waldencast Company Profile

(Free Report)

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

Read More

Want to see what other hedge funds are holding WALD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waldencast plc (NASDAQ:WALDFree Report).

Institutional Ownership by Quarter for Waldencast (NASDAQ:WALD)

Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.